干细胞临床研究的伦理问题反思  

Reflection on Ethical Issues of Stem Cell Clinical Research

作　　者：王佳一 李颖[1,2] 刘晶 WANG Jia-yi;LI Ying;LIU Jing(Regenerative Medicine Center and Stem Cell Clinical Research Center,The First Affiliated Hospital of Dalian Medical University,Dalian 116011,China)

机构地区：[1]大连医科大学附属第一医院再生医学中心和干细胞临床研究中心,辽宁大连116011 [2]大连干细胞与精准医学创新研究院,辽宁大连116011

出　　处：《医学与哲学》2019年第16期6-10,共5页Medicine and Philosophy

基　　金：2015年国家自然科学基金面上项目(81471308);2017年中国国家卫计委和食药监局备案干细胞临床研究项目(CMR-20161129-1003);2016年美国国立卫生研究院临床试验数据中心注册项目(NCT03005249);2018年大连市科技创新基金项目(2018J11CY025)

摘　　要：干细胞研究作为新兴科学技术,受到世界各国重视。近年来,我国在干细胞研究技术、成果转化及临床试验方面取得重要进展。如何使医学为人类服务而不伤害人类已成为现代医学科学研究中的一个重要难题。由于干细胞临床研究涉及人类道德、研究者利益以及受试者安全等,成为了伦理研究争议的焦点。当科技进步与伦理原则相违背时,科技活动的开展仍要坚持遵守正确的伦理规范。因此,中国干细胞临床研究应在伦理学指导下开展,充分尊重和保护受试者,结合中国国情保证干细胞在科学研究过程中应用的合理性,实现科学与伦理学之间的良性互动。As a new science and technology,stem cell research has attracted worldwide attention.In recent years,China has made important progress in stem cell research technology,achievement transformation and clinical trials.How to make medicine serve human beings without harming human beings has become an important issue in modern medical research.Human morality,the interests of researchers and the safety of subjects are the focus of ethical controversy in stem cell research.Though there is conflict between science activities and ethics,the science activities is still regulated by the ethical paradigm.Therefore,stem cell clinical research in China should be conducted under the governance of ethics,fully respect and protect the subjects,ensure the rationality of stem cell application in the process of scientific research,and realize the interaction between science and ethics.

关 键 词：干细胞 临床研究 伦理学 

分 类 号：R-05[医药卫生]